Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Effects of Probiotic Oral Intake on Plasma Chlordecone (Kepone) Concentrations in Individuals Environmentally Exposed to Pesticide in Martinique.
Condition: Chlordecone (Kepone) Toxicity Interventions: Dietary Supplement: Limosilactobacillus reuteri; Other: Placebo Sponsors: University Hospital Center of Martinique; BioGaia AB; University Hospital, Limoges; Regional Health Agency, Martinique; Biological Resource Centre, Martinique; Clinical Research Vigilance Unit, University Hospital, Reims Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials